ZUG, Switzerland--(BUSINESS WIRE)--The joint venture between Biogen (NASDAQ:BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI® , an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback